• 17
  • October
    2011

The U.S. Food and Drug Administration (FDA) has updated its warning on the complications from surgical vaginal mesh implants to treat pelvic organ prolapse (POP). The mesh is used to reinforce the tissue walls. The mesh is a synthetic material that has been the source of thousands of complaints of deteriorating.

A vaginal mesh implant is used to treat both POP and urinary incontinence among other health issues. While a common option for women just a few years ago, awareness of the dangers of the transvaginal mesh has increased rapidly. The FDA has issued the warning about vaginal mesh after receiving 2,874 complaints and reports of health problems following surgery from 2008 to 2010. Prior to 2008, the FDA only received around 1,000.

The main problems associated with the dangerous medical device include deterioration of the mesh, causing pain, bleeding and infection, "pain during intercourse, organ perforation and urinary issues," according to the FDA. These are serious medical complications. The FDA and related studies on the safety of the vaginal mesh encourage women to evaluate other options not involving vaginal synthetic mesh when considering POP or urinary incontinence treatment.

If you've been injured by a vaginal mesh defect in California, contact an experience product liability lawyer today.

Source: FDA "FDA Safety Communication: Update on Serious Complications Associated with Transvaginla Placement on Pelvic Organ Prolapse," 7/13/2011